Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,875,029 papers from all fields of science
Search
Sign In
Create Free Account
SGN-35
Known as:
anti-CD30 ADC SGN-35
, antibody-drug conjugate SGN-35
, ADC SGN-35
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Immunoconjugates
brentuximab vedotin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
A novel anti-CD 37 antibody-drug conjugate with multiple anti-tumor mechanisms for the treatment of B-cell malignancies
J. Deckert
,
Peter U Park
,
+10 authors
J. Lambert
2013
Corpus ID: 42711048
The CD37 antigen is a transmembrane protein of the tetraspanin superfamily that is highly expressed on B cells during the pre-B…
Expand
Review
2012
Review
2012
Перспективы таргетной терапии классической лимфомы Ходжкина
Пархоменко Роман Алексеевич
2012
Corpus ID: 74915653
The survey deals with the latest results of investigations on targeted therapy for classical Hodgkin’s lymphoma (cHL). The most…
Expand
Review
2011
Review
2011
Open access consortium
Stephen E. Strauss
Nature Biotechnology
2011
Corpus ID: 39866678
volume 29 number 4 april 2011 nature biotechnology Another cancer-killing conjugate is ImmunoGen’s IMGN901 (lorvotuzumab…
Expand
2011
2011
Bispecific T Cell Engager for Cancer Therapy
P. Baeuerle
,
G. Zugmaier
,
D. Rüttinger
2011
Corpus ID: 68232940
Treatment with monoclonal antibodies of the human IgG1 and IgG2 isotypes have become a mainstay in cancer therapy, particularly…
Expand
2010
2010
Cancer Therapy : Preclinical Clinical Cancer Research Intracellular Activation of SGN-35 , a Potent Anti-CD 30 Antibody-Drug Conjugate
N. Okeley
,
J. Miyamoto
,
+5 authors
S. Alley
2010
Corpus ID: 2676576
Down Purpose: SGN-35 is an antibody-drug conjugate (ADC) containing the potent antimitotic drug, monomethylauristatin E (MMAE…
Expand
2010
2010
Síndrome linfoproliferativo CD30
L. Calzado-Villarreal
,
I. Polo-Rodríguez
,
P. Ortiz-Romero
2010
Corpus ID: 147875740
Review
2009
Review
2009
FDA Pipeline preview, March 2009 (cetuximab, prasugrel, risperidone, iclaprim, lasofoxifene, ecallantide, laquinimod, C1 inhibitor, SGN-35, omacetaxine)
F. Staff
2009
Corpus ID: 70643253
Recent FDA action (through March 2009) related to cetuximab, prasugrel, risperidone, iclaprim, lasofoxifene, ecallantide…
Expand
1999
1999
Lymphome pilotrope CD30 positif
C. Trémeau-Martinage
,
B. Gorguet
,
+6 authors
J. Bazex
1999
Corpus ID: 141488788
Introduction. Nous rapportons un cas de lymphome cutane CD30+ particulier par son tropisme pilaire, par l'association a des…
Expand
1999
1999
Lymphomes anaplasiques T ou nuls à grandes cellules CD30+ (Ki-1) de l’adulte
L. Cany
,
P. Soubeyran
,
+4 authors
B. Hoerni
1999
Corpus ID: 70422193
Les lymphomes anaplasiques a grandes cellules CD30+/Ki-1+ ont ete individualises par Stein en 1985. En moins de quinze ans, leur…
Expand
Highly Cited
1995
Highly Cited
1995
Low frequency association of the t(2;5)(p23;q35) chromosomal translocation with CD30+ lymphomas from American and Asian patients. A reverse transcriptase-polymerase chain reaction study.
Jean R. Lopategui
,
Li-hua Sun
,
+5 authors
Lawrence M. Weiss
American Journal of Pathology
1995
Corpus ID: 24913530
Although cytogenetic data suggest that the t(2;5)-(p23;q35) translocation occurs in many cases of CD30+ lymphomas, the exact…
Expand